Sophrosyne Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Sophrosyne Capital’s Portfolio BDSI Stock Details BDSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-87,119	Closed	-$913K	–	34
2015 Q1	$913K	Sell	87,119 -124,500	-59%	-$1.7M	1.57%	22
2014 Q4	$2.54M	Buy	211,619 +19,443	+10%	+$295K	3.92%	9
2014 Q3	$3.28M	Sell	192,176 -203,100	-51%	-$2.95M	3.88%	7
2014 Q2	$4.77M	Sell	395,276 -122,386	-24%	-$1.16M	4.86%	7
2014 Q1	$4.37M	Sell	517,662 -177,300	-26%	-$1.43M	3.83%	9
2013 Q4	$4.09M	Sell	694,962 -779,944	-53%	-$4.02M	3.58%	9
2013 Q3	$8.01M	Hold	1,474,906	–	–	5.3%	5
2013 Q2	$5.99M	Buy	+1,474,906	New	+$6.92M	4.7%	6

Other funds holding BDSI

FHC

First Heartland Consultants Lake St. Louis, Missouri $1.55B AUM 20.5% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

ORI

Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Sophrosyne Capital's BDSI Position: Q2 2015 in Review

Sophrosyne Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 87,119 shares — an estimated $913K sold.

Sophrosyne Capital first reported a position in BDSI in Q2 2013 and held it in 8 quarters. The position peaked at $8.01M in Q3 2013. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

Sophrosyne Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
Sophrosyne Capital sold 87,119 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $913K.
Sophrosyne Capital first reported a position in BioDelivery Sciences International, Inc. in Q2 2013 and held it in 8 quarters.
Sophrosyne Capital's BioDelivery Sciences International, Inc. position peaked at $8.01M in Q3 2013.
143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on Sophrosyne Capital's 13F filing for Q2 2015, filed 14 Aug 2015.